Shareholders to Vote on Reverse Stock Split to Avoid Delisting and Massive Warrant Dilution

summarizeSummary

LM Funding America is holding an annual meeting to vote on a reverse stock split to avoid Nasdaq delisting and to approve the potential issuance of over 12.6 million shares from warrants, which could result in approximately 77.8% dilution.

check_boxKey Events · Corporate Governance and Compliance · LMFA

• Definitive Proxy Filed for Annual Meeting

  This DEF 14A finalizes the proposals and sets the Annual Meeting for June 16, 2026, following a preliminary proxy statement filed on April 16, 2026.

• Reverse Stock Split Proposed to Avoid Delisting

  Shareholders will vote on a reverse stock split with a ratio between 1:5 and 1:25. This action is critical to regain compliance with Nasdaq's $1.00 minimum bid price requirement, following a delisting notice received on January 7, 2026.

• Massive Potential Dilution from Warrant Approvals

  Shareholder approval is sought for the potential issuance of 12,627,670 shares upon the exercise of common warrants from a December 2025 offering and repriced warrants from December 2024. This represents approximately 77.8% dilution relative to the 16,216,778 shares outstanding as of April 21, 2026.

• Significant Capital Raised Amidst Distress

  The December 2025 offering, which included shares and pre-funded warrants already issued, generated approximately $6.0 million in gross proceeds. This capital raise is substantial for the company, which reported a $27 million net loss in 2025.

auto_awesomeAnalysis · LMFA · Crypto Assets

This definitive proxy statement outlines critical proposals for LM Funding America's upcoming annual meeting, finalizing plans previously disclosed in a preliminary filing. The company is seeking shareholder approval for a reverse stock split (1:5 to 1:25 ratio) as a direct response to a Nasdaq delisting notice, indicating severe financial distress and a struggle to maintain its public listing. Concurrently, shareholders will vote on the potential issuance of over 12.6 million shares from the exercise of warrants, including a significant repricing of older warrants and new warrants from a December 2025 offering that raised $6.0 million. This potential dilution of approximately 77.8% relative to current outstanding shares is substantial for a company with a market capitalization of just $3.8 million and a history of significant net losses, including a $27 million loss in 2025. While the capital raise provides a lifeline, the combined effect of a reverse split and massive dilution presents a highly negative outlook for existing shareholders.